Leap Therapeutics

$1.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 6:17 PM UTC today

Why Robinhood?

You can buy or sell LPTX and other stocks, options, and ETFs commission-free!

About LPTX

Leap Therapeutics, Inc. Common Stock, also called Leap Therapeutics, is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer.

CEO

Doug E. Onsi

Employees

Headquarters

Cambridge, Massachusetts

Founded

2011

Market Cap

104.03M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

520.15K

High Today

$1.66

Low Today

$1.60

Open Price

$1.61

Volume

209.01K

52 Week High

$3.24

52 Week Low

$1.43

LPTX Earnings

-$0.55

-$0.37

-$0.18

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, Pre-Market